J. Nat. Prod., 66 (12), 1567 -1573, 2003. 10.1021/np030266u S0163-3864(03)00266-0
Web Release Date: November 25, 2003

Copyright © 2003 American Chemical Society and American Society of Pharmacognosy

Cytotoxic Constituents of Aspergillus terreus from the Rhizosphere of Opuntia versicolor of the Sonoran Desert

E. M. Kithsiri Wijeratne, Thomas J. Turbyville, Zhongge Zhang, Donna Bigelow, Leland S. Pierson, III, Hans D. VanEtten, Luke Whitesell, Louise M. Canfield, and A. A. Leslie Gunatilaka*

SW Center for Natural Products Research and Commercialization, Office of Arid Lands Studies, College of Agriculture and Life Sciences, University of Arizona, 250 E. Valencia Road, Tucson, Arizona 85706-6800, Department of Plant Pathology, College of Agriculture and Life Sciences, University of Arizona, Tucson, Arizona 85721-0036, Division of Pediatric Hematology/Oncology, Steele Memorial Children's Research Center, University of Arizona, Tucson, Arizona 85724, and Department of Biochemistry and Biophysics, University of Arizona, Tucson, Arizona 85721-5042

Received June 11, 2003

Abstract:

A novel cyclopentenedione, asterredione (1), two new terrecyclic acid A derivatives, (+)-5(6)-dihydro-6-methoxyterrecyclic acid A (2) and (+)-5(6)-dihydro-6-hydroxyterrecyclic acid A (3), and five known compounds, (+)-terrecyclic acid A (4), (-)-quadrone (5), betulinan A (6), asterriquinone D (7), and asterriquinone C-1 (8), were isolated from Aspergillus terreus occurring in the rhizosphere of Opuntia versicolor, using bioassay-guided fractionation. Acid-catalyzed reaction of 2 under mild conditions afforded 4, whereas under harsh conditions 2 yielded 5 and (-)-isoquadrone (9). Catalytic hydrogenation and methylation of 4 afforded 5(6)-dihydro-terrecyclic acid A (10) and (+)-terrecyclic acid A methyl ester (11), respectively. The structures of 1-11 were elucidated by spectroscopic methods. All compounds were evaluated for cytotoxicity in a panel of three sentinel cancer cell lines, NCI-H460 (non-small cell lung cancer), MCF-7 (breast cancer), and SF-268 (CNS glioma), and were found to be moderately active. Cell cycle analysis of 2, 4, and 5 using the NCI-H460 cell line indicated that 4 is capable of disrupting the cell cycle through an apparent arrest to progression at the G1 and G2/M phases in this p53 competent cell line. A pathway for the biosynthetic origin of asterredione (1) from asterriquinone D (7) is proposed.


Download the full text: PDF | HTML